Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Plazomicin Retains Antibiotic Activity against Most Aminoglycoside Modifying Enzymes

Journal Article · · ACS Infectious Diseases

Plazomicin is a next-generation, semisynthetic aminoglycoside antibiotic currently under development for the treatment of infections due to multidrug-resistant Enterobacteriaceae. The compound was designed by chemical modification of the natural product sisomicin to provide protection from common aminoglycoside modifying enzymes that chemically alter these drugs via N-acetylation, O-adenylylation, or O-phosphorylation. In this study, plazomicin was profiled against a panel of isogenic strains of Escherichia coli individually expressing twenty-one aminoglycoside resistance enzymes. Plazomicin retained antibacterial activity against 15 of the 17 modifying enzyme-expressing strains tested. Expression of only two of the modifying enzymes, aac(2')-Ia and aph(2'')-IVa, decreased plazomicin potency. On the other hand, expression of 16S rRNA ribosomal methyltransferases results in a complete lack of plazomicin potency. In vitro enzymatic assessment confirmed that AAC(2')-Ia and APH(2'')-IVa (aminoglycoside acetyltransferase, AAC; aminoglycoside phosphotransferase, APH) were able to utilize plazomicin as a substrate. AAC(2')-Ia and APH(2'')-IVa are limited in their distribution to Providencia stuartii and Enterococci, respectively. These data demonstrate that plazomicin is not modified by a broad spectrum of common aminoglycoside modifying enzymes including those commonly found in Enterobacteriaceae. However, plazomicin is inactive in the presence of 16S rRNA ribosomal methyltransferases, which should be monitored in future surveillance programs.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (US). Advanced Photon Source (APS)
Sponsoring Organization:
USDOE Office of Science (SC)
OSTI ID:
1459983
Journal Information:
ACS Infectious Diseases, Journal Name: ACS Infectious Diseases Journal Issue: 6 Vol. 4; ISSN 2373-8227
Publisher:
American Chemical Society (ACS)Copyright Statement
Country of Publication:
United States
Language:
ENGLISH

References (32)

Aminoglycoside-modifying enzymes journal October 1999
Aminoglycoside binding and catalysis specificity of aminoglycoside 2″-phosphotransferase IVa: A thermodynamic, structural and kinetic study journal April 2016
A Small Molecule Discrimination Map of the Antibiotic Resistance Kinome journal December 2011
A Common Platform for Antibiotic Dereplication and Adjuvant Discovery journal January 2017
Evolving medicinal chemistry strategies in antibiotic discovery journal December 2016
Aminoglycoside modifying enzymes journal December 2010
Aminoglycoside Resistance journal June 2016
In-vitro activity of several antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA) isolates expressing aminoglycoside-modifying enzymes: potency of plazomicin alone and in combination with other agents journal August 2017
Aminoglycoside Resistance by ArmA-mediated Ribosomal 16S Methylation in Human Bacterial Pathogens journal June 2006
Combating evolution with intelligent design: the neoglycoside ACHN-490 journal October 2010
Mechanism of Aminoglycoside Antibiotic Kinase APH(3‘)-IIIa:  Role of the Nucleotide Positioning Loop journal June 2002
Crystal Structures of Antibiotic-Bound Complexes of Aminoglycoside 2′′-Phosphotransferase IVa Highlight the Diversity in Substrate Binding Modes among Aminoglycoside Kinases journal July 2011
Antibacterial drug discovery in the resistance era journal January 2016
Mechanisms of resistance to aminoglycoside antibiotics: overview and perspectives journal January 2016
Drug-target networks in aminoglycoside resistance: hierarchy of priority in structural drug design journal January 2016
Inducible expression of an aminoglycoside-acetylating enzyme in Providencia stuartii journal January 1987
Structural basis for the methylation of A1408 in 16S rRNA by a panaminoglycoside resistance methyltransferase NpmA from a clinical isolate and analysis of the NpmA interactions with the 30S ribosomal subunit journal November 2010
Coot model-building tools for molecular graphics journal November 2004
XDS journal January 2010
PHENIX: a comprehensive Python-based system for macromolecular structure solution journal January 2010
Overview of the CCP 4 suite and current developments journal March 2011
Transferable Resistance to Aminoglycosides by Methylation of G1405 in 16S rRNA and to Hydrophilic Fluoroquinolones by QepA-Mediated Efflux in Escherichia coli journal July 2007
Synthesis and Spectrum of the Neoglycoside ACHN-490 journal August 2010
Association between the Presence of Aminoglycoside-Modifying Enzymes and In Vitro Activity of Gentamicin, Tobramycin, Amikacin, and Plazomicin against Klebsiella pneumoniae Carbapenemase- and Extended-Spectrum-β-Lactamase-Producing Enterobacter Species journal September 2016
Novel Plasmid-Mediated 16S rRNA m1A1408 Methyltransferase, NpmA, Found in a Clinically Isolated Escherichia coli Strain Resistant to Structurally Diverse Aminoglycosides journal September 2007
Plazomicin Activity against 346 Extended-Spectrum-β-Lactamase/AmpC-Producing Escherichia coli Urinary Isolates in Relation to Aminoglycoside-Modifying Enzymes journal February 2017
A New High-Level Gentamicin Resistance Gene, aph(2")-Id , in Enterococcus spp journal May 1998
Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. journal January 1993
Contribution of gentamicin 2'-N-acetyltransferase to the O acetylation of peptidoglycan in Providencia stuartii journal August 1995
Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes journal March 1993
The chromosomal 2'-N-acetyltransferase of providencia stuartii: physiological functions and genetic regulation journal January 1999
Antibiotic 6640, a new Micromonospora-Producbd Aminoglycoside Antibiotic journal January 1970

Cited By (11)

Teaching an Old Class New Tricks: A Novel Semi-Synthetic Aminoglycoside, Plazomicin journal March 2019
Evaluation of Plazomicin, Tigecycline, and Meropenem Pharmacodynamic Exposure against Carbapenem-Resistant Enterobacteriaceae in Patients with Bloodstream Infection or Hospital-Acquired/Ventilator-Associated Pneumonia from the CARE Study (ACHN-490-007) journal June 2019
Plazomicin Is Active Against Metallo-β-Lactamase-Producing Enterobacteriaceae journal March 2019
Discovery of a novel integron-borne aminoglycoside resistance gene present in clinical pathogens by screening environmental bacterial communities journal March 2020
Synthesis of saccharocin from apramycin and evaluation of its ribosomal selectivity journal January 2019
Recent advances in antibacterial applications of metal nanoparticles (MNPs) and metal nanocomposites (MNCs) against multidrug-resistant (MDR) bacteria journal May 2019
In vitro activity of apramycin against multidrug-, carbapenem- and aminoglycoside-resistant Enterobacteriaceae and Acinetobacter baumannii journal January 2019
In Vitro Activity of Plazomicin against Gram-Negative and Gram-Positive Isolates Collected from U.S. Hospitals and Comparative Activities of Aminoglycosides against Carbapenem-Resistant Enterobacteriaceae and Isolates Carrying Carbapenemase Genes journal June 2018
In Vitro Activity of Plazomicin Compared to Amikacin, Gentamicin, and Tobramycin against Multidrug-Resistant Aerobic Gram-Negative Bacilli journal November 2019
In vitro activity of apramycin against multidrug-, carbapenem- and aminoglycoside-resistant Enterobacteriaceae and Acinetobacter baumannii text January 2019
Synthesis of saccharocin from apramycin and evaluation of its ribosomal selectivity text January 2019

Figures / Tables (6)


Similar Records

Structural basis for the diversity of the mechanism of nucleotide hydrolysis by the aminoglycoside-2"-phosphotransferases
Journal Article · Thu Nov 28 23:00:00 EST 2019 · Acta Crystallographica. Section D. Structural Biology · OSTI ID:1595141

Structural Basis of APH(3)-IIIa-Mediated Resistance to N1-Substituted Aminoglycoside Antibiotics
Journal Article · Wed Dec 31 23:00:00 EST 2008 · Antimicrobial Agents and Chemotherapy · OSTI ID:980508